Genscript Biotech

Genscript Biotech Cash Flow per Share

The Operating Cash Flow per Share of Genscript Biotech (1548.HK) as of Oct 11, 2026 is 0.15 USD.

Cash Flow per Share

0.15USD

YoY

3,199.97%

Last updated:

Operating Cash Flow per Share of Genscript Biotech is 2025 0.15 USD. Operating Cash Flow per Share of Genscript Biotech was 2024 0.00 USD. It decreases by 3,199.97% higher compared to the previous year.

The Genscript Biotech Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
0.17 USD
Jan 1, 2019
-0.02 USD
Jan 1, 2020
-0.08 USD
Jan 1, 2021
-0.07 USD
Jan 1, 2022
-0.06 USD
Jan 1, 2023
-0.14 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.15 USD
The Genscript Biotech Cash Flow per Share history
YEARCash Flow per ShareYoY
0.15USD+3,199.97%
0.00USD-103.26%
-0.14USD+137.56%
-0.06USD-12.81%
-0.07USD-15.20%
-0.08USD+385.06%
-0.02USD-109.63%
0.17USD+1,238.28%
0.01USD-35.86%
0.02USD+21.83%
0.02USD+59.36%
0.01USD—
Access this data via the Eulerpool API
Get Free API Key

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

Operating Cash Flow per Share of Genscript Biotech is 0.15 USD in 2025.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Genscript Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genscript Biotech